Fudan University
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Study of Weekly DCF to Treat Advanced Gastric Cancer
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2010-01-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT00568971
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2009-07-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 10
- Registration Number
- NCT00568464
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 31
- Registration Number
- NCT00568815
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT00568529
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2010-09-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT00568607
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
- Conditions
- Interventions
- First Posted Date
- 2007-11-21
- Last Posted Date
- 2010-07-21
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 290
- Registration Number
- NCT00561522
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
- First Posted Date
- 2007-11-06
- Last Posted Date
- 2007-11-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 220
- Registration Number
- NCT00554125
- Locations
- 🇨🇳
Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China
Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
- Conditions
- Interventions
- First Posted Date
- 2007-09-06
- Last Posted Date
- 2007-09-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 603
- Registration Number
- NCT00525642
- Locations
- 🇨🇳
No2 affiliated hospital of Sun Yat-sen medical Univesity, Guangzhou, Guangdong, China
🇨🇳Beijing 307 Hospital, Beijing, Beijing, China
🇨🇳Liaoning Province Cancer Hospital, Shenyang, Liaoning, China
Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis
- First Posted Date
- 2007-09-05
- Last Posted Date
- 2010-09-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT00524849
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
The Protocol of Enhanced Recovery After Surgery in Colorectal Surgery
- Conditions
- Interventions
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 500
- Registration Number
- NCT00498290
- Locations
- 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China